Pfizer And Medivation, Inc. Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer`s Disease
Pfizer And Medivation, Inc. Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer`s Disease
Reuters Key Development - 1 hour ago